Eric Karas - Chief Commercial Officer at ARS Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
SPRY on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Eric Karas - trading volume in the past year for ARS Pharmaceuticals, Inc.

Holdings reported by Eric Karas for ARS Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 5.69K $79.7K $14.00 Dec 4, 2024 Direct
Stock Option (Right to Buy) 585K Dec 4, 2024 Direct Common Stock

Transactions reported by Eric Karas for ARS Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.